 Recursion Pharma is hoping to revolutionize drug discovery with its Recursion OS technology; potential to improve drug discovery and processing capabilities. Recent deal with Roche brought in an upfront payment of 150 million, with potential to earn up to 300 million for each of the 40 programs to possibly be advanced. 